SCYNEXIS是一家生物科技企业,专注于研发创新抗真菌疗法,用于治疗难治性真菌感染,满足未被覆盖的医疗需求,主要面向医院及专科护理市场,核心产品管线覆盖免疫低下患者等高危人群。
CTMX
CytomX Therapeutics, Inc.
营收
$18.7M
净利润
$-154.0K
ENTA
ENANTA PHARMACEUTICALS INC
$18.6M
$-11.9M
RMTI
ROCKWELL MEDICAL, INC.
$18.3M
$-554.0K
RWT
REDWOOD TRUST INC
$25.9M
$20.0M
RDHL
RedHill Biopharma Ltd.
$-11.7M
NAMS
凯特制药
$19.1M
$-17.4M
FXNC
FIRST NATIONAL CORP
$24.0M
$5.5M
CYTK
CYTOKINETICS INC
$17.8M
$-183.0M